ZBH
NYSEZIMMER BIOMET HOLDINGS, INC.
Health Care, Health Care Equipment
$96.55
close 7 Aug 2026
-3.47%
52-week change
$18.42B
market cap
$79.12
$108.29
52-week range
| Line item | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income | ||||||||||||||||||||
| Revenue | $8.51B | $8.23B | $7.68B | $7.39B | $6.94B | $6.83B | $6.13B | $7.98B | $7.93B | $7.80B | $7.67B | $6.00B | $4.67B | $4.62B | $4.47B | $4.45B | $4.22B | $4.10B | $4.12B | $3.90B |
| Cost of revenue | $2.56B | $2.49B | $2.19B | $2.08B | $2.02B | $1.96B | $1.82B | $2.25B | $2.27B | $2.13B | $2.38B | $1.80B | $1.24B | $1.27B | $1.13B | $1.12B | $1.01B | $990.70M | $997.30M | $875.90M |
| Gross profit | — | — | — | — | — | — | — | — | — | — | — | — | $3.42B | $3.34B | $3.35B | $3.33B | $3.21B | $3.10B | $3.12B | $3.02B |
| R&D | $442.80M | $458.50M | $437.40M | $458.70M | $406.00M | $435.80M | $322.80M | $449.30M | $391.70M | $369.90M | $365.60M | $268.80M | $187.40M | $203.00M | $225.60M | $238.40M | $218.50M | $205.70M | $192.30M | $182.60M |
| SG&A | $3.43B | $3.26B | $2.93B | $2.84B | $2.76B | $2.84B | $2.71B | $3.34B | $3.38B | $3.10B | $2.94B | $2.28B | $1.75B | $1.75B | $1.81B | $1.83B | $1.76B | $1.73B | $1.70B | $1.52B |
| Operating income | $1.21B | $1.10B | $1.29B | $1.28B | $696.30M | $860.30M | $83.10M | $1.14B | $33.80M | $799.30M | $821.10M | $467.30M | $1.04B | $1.07B | $1.05B | $1.02B | $916.70M | $1.02B | $1.09B | $1.13B |
| Interest expense | — | — | — | — | — | — | — | — | — | $327.50M | $357.90M | $286.60M | $63.10M | $70.10M | $72.90M | $55.30M | $60.20M | $22.40M | — | — |
| Tax expense | $126.50M | $125.70M | $131.40M | $42.20M | $112.30M | $53.50M | -$96.00M | -$225.70M | $108.20M | -$1.35B | $95.00M | $7.00M | $220.20M | $229.50M | $237.20M | $218.90M | $263.30M | $280.80M | $272.30M | $357.90M |
| Net income | $806.70M | $705.10M | $903.80M | $1.02B | $231.40M | $401.60M | -$138.90M | $1.13B | -$379.20M | $1.81B | $305.90M | $147.00M | $720.30M | $780.40M | $755.00M | $760.80M | $596.90M | $717.40M | $848.60M | $773.20M |
| Diluted EPS | $4.12 | $3.55 | $4.43 | $4.88 | $1.10 | $1.91 | -$0.6700 | $5.47 | -$1.86 | $8.90 | $1.51 | $0.7700 | $4.20 | $4.54 | $4.29 | $4.03 | $2.97 | $3.32 | $3.72 | $3.26 |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — | — | 73.26% | 72.18% | 74.84% | 74.80% | 76.02% | 75.81% | 75.80% | 77.53% |
| Operating margin | 14.16% | 13.34% | 16.74% | 17.28% | 10.03% | 12.60% | 1.36% | 14.25% | 0.43% | 10.24% | 10.71% | 7.79% | 22.20% | 23.11% | 23.42% | 23.00% | 21.72% | 24.88% | 26.45% | 28.93% |
| Net margin | 9.48% | 8.57% | 11.77% | 13.85% | 3.33% | 5.88% | -2.27% | 14.18% | -4.78% | 23.24% | 3.99% | 2.45% | 15.41% | 16.88% | 16.88% | 17.09% | 14.14% | 17.52% | 20.59% | 19.84% |
filed 5 Aug 2026